Healthy VolunteersNCT02403609
An Online Study of the Reliability of the Brain Performance Test (BPT)
A study testing BPT, Computerized Assessment in people with Healthy Volunteers, run by Lumos Labs, Inc. at 1 site in United States.
Trial summary
The purpose of this study is to evaluate test-retest reliability of each subtest (correlation coefficients for Time 1 and 2) in the Brain Performance Test (BPT, Lumos Labs, Inc.). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Healthy Volunteers
- What is being tested?
- BPT, Computerized Assessment
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,357 participants
- Where
- 1 siteUnited States
- Study dates
- Mar 2015to Dec 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 18 years of age or older
- Electronically signed informed consent
- English-speaker
- Current Lumosity free user (test-retest portion) OR current Lumosity subscriber (longitudinal portion)
Who cannot join
- Visual or physical impairment that impedes computer use or completion
- Under 18 years of age
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to evaluate test-retest reliability of each subtest (correlation coefficients for Time 1 and 2) in the Brain Performance Test (BPT, Lumos Labs, Inc.).
Read the detailed description
This is an open-label, randomized online study in which participants will be invited to take versions of the Brain Performance Test (BPT) on two consecutive days.
In parallel, all current Lumosity subscribers are invited to take the BPT at the beginning of their premium Lumosity experience and again every 10 weeks.
- Conditions
- Healthy Volunteers
- Being tested
- BPT, Computerized Assessment
- Keywords
- cognitive assessment, Brain Performance Test, Lumosity, test-retest reliability, computerized assessment
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BPT, Computerized AssessmentOther
| Study group | Role | What they receive |
|---|---|---|
| BPT, Computerized Assessment | Experimental | Participants will first take the Brain Performance Test (BPT) on two consecutive days Receives: Other: BPT, Computerized Assessment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Correlation coefficients (Pearson's r)
Correlation coefficients (Pearson's r) of scaled scores of BPT subtests at Time 1 compared to Time 2
Measured: 2 days
Secondary outcomes (3)
Intercorrelation coefficients (Pearson's r)
Intercorrelation coefficients (Pearson's r) of scaled scores of BPT subtests at Time 1
Measured: 1 day
Principle component analysis
Principle component analysis of scaled scores of BPT subtests at Time 1
Measured: 1 day
Longitudinal BPT Grand Index and Subtest scaled scores
Measured: 10 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Mar 2015 (estimated)
- Study startMar 2015
- Primary completionDec 2015
- Study completionDec 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy VolunteersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 1,357 participants (actual)
Sponsor and investigators
- Lead sponsor
- Lumos Labs, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Glenn Morrison, PhD, Principal investigator, Lumos Labs, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02403609
- Sponsor's protocol ID
- LL003
- Status last verified
- Mar 2016
- First submitted
- 26 Mar 2015
- Last updated
- 3 Mar 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Mar 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Online Study of the Reliability of the Brain Performance Test (BPT)
- ClinicalTrials.gov ID
- NCT02403609
- Acronym / sponsor ID
- LL003
- Conditions
- Healthy Volunteers
- Keywords
- cognitive assessment, Brain Performance Test, Lumosity, test-retest reliability, computerized assessment
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,357 participants (actual)
- Lead sponsor
- Lumos Labs, Inc.Industry (pharma, biotech, devices)
- Study start
- Mar 2015
- Primary completion
- Dec 2015 (actual)
- Study completion
- Dec 2015 (actual)
- First posted
- 31 Mar 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate test-retest reliability of each subtest (correlation coefficients for Time 1 and 2) in the Brain Performance Test (BPT, Lumos Labs, Inc.).
Detailed description
This is an open-label, randomized online study in which participants will be invited to take versions of the Brain Performance Test (BPT) on two consecutive days.
In parallel, all current Lumosity subscribers are invited to take the BPT at the beginning of their premium Lumosity experience and again every 10 weeks.
Study design
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| BPT, Computerized Assessment | Experimental | Other: BPT, Computerized AssessmentParticipants will first take the Brain Performance Test (BPT) on two consecutive days |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- 18 years of age or older
- Electronically signed informed consent
- English-speaker
- Current Lumosity free user (test-retest portion) OR current Lumosity subscriber (longitudinal portion)
Key exclusion criteria (2 listed)
- Visual or physical impairment that impedes computer use or completion
- Under 18 years of age
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BPT, Computerized Assessment | Other | BPT, Computerized Assessment |
Primary outcome
Correlation coefficients (Pearson's r)
Time frame: 2 days
Correlation coefficients (Pearson's r) of scaled scores of BPT subtests at Time 1 compared to Time 2
3 secondary outcomes
Intercorrelation coefficients (Pearson's r)
Time frame: 1 day
Principle component analysis
Time frame: 1 day
Longitudinal BPT Grand Index and Subtest scaled scores
Time frame: 10 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Mar 2016.
- Click here for more information about Lumosity's Human Cognition Project.Link provided by the sponsor.
Related trials for Healthy Volunteers
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Not yet recruitingObservational study
Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Healthy
RecruitingObservational study
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Graft-Versus-Host Disease, Graft-versus-leukemia
Not yet recruitingObservational study
Screening Protocol
Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Glenn Morrison, PhD principal investigator
Lumos Labs, Inc.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing BPT, Computerized Assessment in people with Healthy Volunteers, run by Lumos Labs, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Mar 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Correlation coefficients (Pearson's r) (time frame: 2 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2016.